Keyphrases
Interferon-γ
100%
Recombinant Human
100%
Metastatic Renal Cell Carcinoma (mRCC)
100%
Recombinant Interferon
80%
Hemoglobin
40%
Response Proportions
40%
Headache
20%
Disease Progression
20%
Open-label Trial
20%
Median Survival
20%
Improved Survival
20%
High Performance
20%
Adverse Events
20%
Nausea
20%
Fever
20%
Multivariate Analysis
20%
Young Age
20%
Performance Status
20%
Objective Response
20%
Single Center
20%
Duration of Response
20%
Complete Response
20%
Partial Response
20%
Complete Response Rate
20%
Male Sex
20%
Pretreatment Variables
20%
Karnofsky Performance Status
20%
Asthenia
20%
Pharmacology, Toxicology and Pharmaceutical Science
Kidney Metastasis
100%
Recombinant Gamma Interferon
100%
Gamma1b Interferon
80%
Lactate Dehydrogenase
40%
Headache
20%
Adverse Event
20%
Disease Exacerbation
20%
Nausea
20%
Open-Label Trial
20%
Chill
20%
Asthenia
20%